Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice

Journal of Neuroimmunology

Volumn 298, Issue , 2016, Pages 106-116

  Ozgun Acar, Ozden ^a   Celik Turgut, Gurbet ^a   Gazioglu, Isil ^b   Kolak, Ufuk ^c   Ozbal, Seda ^d   Ergur, Bekir U ^d   Arslan, Sevki ^a   Sen, Alaattin ^a   Topcu, Gulacti ^b  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Anti neuroinflammatory; Capparis ovata; Cytokine expression; Experimental allergic encephalomyelitis; Immunohistochemistry; LC MS MS; Multiple sclerosis; Transcriptome profiling

Indexed keywords

CAPPARIS OVATA EXTRACT; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PLANT EXTRACT; RANTES; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); MYELIN PROTEIN; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BUD; C57BL 6 MOUSE; CAPPARIS; CAPPARIS OVATA; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOWER; FRUIT; GENE CONTROL; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LIQUID CHROMATOGRAPHY; MOUSE; MOUSE MODEL; MULTIPLE SCLEROSIS; MYELINATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REMYELINIZATION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TISSUE SECTION; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYTOTHERAPY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CAPPARIS; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MYELIN PROTEINS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 84978706349     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.07.010     Document Type: Article

References (44)

1. Akgul, A., Ozcan, M., Some compositional characteristics of capers (Capparis spp.) seed and oil. Grasas Aceites 50 (1999), 49–52.
2. Andersson, A., Karlsson, J., Genetics of experimental autoimmune encephalomyelitis in the mouse. Arch. Immunol. Ther. Exp. 52 (2004), 316–325.
3. Bar-Or, A., Oliveira, E.M., Anderson, D.E., Hafler, D.A., Molecular pathogenesis of multiple sclerosis. J. Neuroimmunol. 100 (1999), 252–259.
4. Baytop, T., Therapy with Medicinal Plants in Turkey (Past and Present). 1999, Nobel Tip, Istanbul, 480.
5. Bektas, N., Arslan, R., Goger, F., Kirimer, N., Ozturk, Y., Investigation for anti-inflammatory and anti-thrombotic activities of methanol extract of Capparis ovata buds and fruits. J. Ethnopharmacol. 142 (2012), 48–52.
6. Çaliş, İ., Kuruüzüm, A., Rüedi, P., 1H-Indole-3 acetonitrile glycosides from Capparis spinosa fruits. Phytochemistry 50 (1999), 1205–1208.
7. Celik, G., Ozgun, O., Arslan, S., Sen, A., Toxicogenomic analysis of Capparis ovata water extract (MSCov). FEBS J., 281(S1), 2014, 184.
8. Chitnis, T., Khoury, S.J., Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol. Res. 28 (2003), 223–239.
9. Davis, P.H., Flora of Turkey and the East Aegean Islands. 1965, Edinburgh University Press.
10. Duman, E., Ozcan, M.M., Physicochemical properties of seeds of Capparis species growing wild in Turkey. Environ. Monit. Assess. 186 (2014), 2393–2398.
11. Duman, H., Canatan, D., Alanoglu, G., Sutçu, R., Nayır, T., The antioxidant effects of Capparis ovata and deferasirox in patients with thalassemia major. J. Blood Disord. Transfus., 2013.
12. Farooqi, N., Gran, B., Constantinescu, C.S., Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?. J. Neurochem. 115 (2010), 829–844.
13. Ghazalpour, A., Bennett, B., Petyuk, V.A., Orozco, L., Hagopian, R., Mungrue, I.N., Farber, C.R., Sinsheimer, J., Kang, H.M., Furlotte, N., Park, C.C., Wen, P.Z., Brewer, H., Weitz, K., Camp, D.G. II, Pan, C., Yordanova, R., Neuhaus, I., Tilford, C., Siemers, N., Gargalovic, P., Eskin, E., Kirchgessner, T., Smith, D.J., Smith, R.D., Lusis, A.J., Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet., 7, 2011, e1001393.
14. Gilgun-Sherki, Y., Melamed, E., Offen, D., The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 251 (2004), 261–268.
15. Gören, A.C., Bilsel, G., Bilsel, M., Rapid and simultaneous determination of 25-OH-vitamin D2 and D3 in human serum by LC/MS/MS: validation and uncertainty assessment. J. Chem. Metrol. 1 (2007), 1–9.
16. International Multiple Sclerosis Genetics, C., Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., Booth, D., Goris, A., Oturai, A., Saarela, J., Fontaine, B., Hemmer, B., Martin, C., Zipp, F., D'Alfonso, S., Martinelli-Boneschi, F., Taylor, B., Harbo, H.F., Kockum, I., Hillert, J., Olsson, T., Ban, M., Oksenberg, J.R., Hintzen, R., Barcellos, L.F., C. Wellcome Trust Case Control, I. B. D. G. C. International, Agliardi, C., Alfredsson, L., Alizadeh, M., Anderson, C., Andrews, R., Sondergaard, H.B., Baker, A., Band, G., Baranzini, S.E., Barizzone, N., Barrett, J., Bellenguez, C., Bergamaschi, L., Bernardinelli, L., Berthele, A., Biberacher, V., Binder, T.M., Blackburn, H., Bomfim, I.L., Brambilla, P., Broadley, S., Brochet, B., Brundin, L., Buck, D., Butzkueven, H., Caillier, S.J., Camu, W., Carpentier, W., Cavalla, P., Celius, E.G., Coman, I., Comi, G., Corrado, L., Cosemans, L., Cournu-Rebeix, I., Cree, B.A., Cusi, D., Damotte, V., Defer, G., Delgado, S.R., Deloukas, P., di Sapio, A., Dilthey, A.T., Donnelly, P., Dubois, B., Duddy, M., Edkins, S., Elovaara, I., Esposito, F., Evangelou, N., Fiddes, B., Field, J., Franke, A., Freeman, C., Frohlich, I.Y., Galimberti, D., Gieger, C., Gourraud, P.A., Graetz, C., Graham, A., Grummel, V., Guaschino, C., Hadjixenofontos, A., Hakonarson, H., Halfpenny, C., Hall, G., Hall, P., Hamsten, A., Harley, J., Harrower, T., Hawkins, C., Hellenthal, G., Hillier, C., Hobart, J., Hoshi, M., Hunt, S.E., Jagodic, M., Jelcic, I., Jochim, A., Kendall, B., Kermode, A., Kilpatrick, T., Koivisto, K., Konidari, I., Korn, T., Kronsbein, H., Langford, C., Larsson, M., Lathrop, M., Lebrun-Frenay, C., Lechner-Scott, J., Lee, M.H., Leone, M.A., Leppa, V., Liberatore, G., Lie, B.A., Lill, C.M., Linden, M., Link, J., Luessi, F., Lycke, J., Macciardi, F., Mannisto, S., Manrique, C.P., Martin, R., Martinelli, V., Mason, D., Mazibrada, G., McCabe, C., Mero, I.L., Mescheriakova, J., Moutsianas, L., Myhr, K.M., Nagels, G., Nicholas, R., Nilsson, P., Piehl, F., Pirinen, M., Price, S.E., Quach, H., Reunanen, M., Robberecht, W., Robertson, N.P., Rodegher, M., Rog, D., Salvetti, M., Schnetz-Boutaud, N.C., Sellebjerg, F., Selter, R.C., Schaefer, C., Shaunak, S., Shen, L., Shields, S., Siffrin, V., Slee, M., Sorensen, P.S., Sorosina, M., Sospedra, M., Spurkland, A., Strange, A., Sundqvist, E., Thijs, V., Thorpe, J., Ticca, A., Tienari, P., van Duijn, C., Visser, E.M., Vucic, S., Westerlind, H., Wiley, J.S., Wilkins, A., Wilson, J.F., Winkelmann, J., Zajicek, J., Zindler, E., Haines, J.L., Pericak-Vance, M.A., Ivinson, A.J., Stewart, G., Hafler, D., Hauser, S.L., Compston, A., McVean, G., De Jager, P., Sawcer, S.J., McCauley, J.L., Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45 (2013), 1353–1360.
17. Johnson, R.W., Feeding the beast: can microglia in the senescent brain be regulated by diet?. Brain Behav. Immun. 43 (2015), 1–8.
18. Lassmann, H., van Horssen, J., The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett. 585 (2011), 3715–3723.
19. Leong, E.M., Semple, S.J., Angley, M., Siebert, W., Petkov, J., McKinnon, R.A., Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?. Complement. Ther. Med. 17 (2009), 216–223.
20. Lim, E.T., Giovannoni, G., Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis. Expert. Rev. Neurother. 5 (2005), 379–390.
21. Linker, R.A., Lee, D.H., Ryan, S., van Dam, A.M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., Ellrichmann, G., Bruck, W., Dawson, K., Goelz, S., Wiese, S., Scannevin, R.H., Lukashev, M., Gold, R., Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134 (2011), 678–692.
22. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25 (2001), 402–408.
23. Marrie, R.A., Hadjimichael, O., Vollmer, T., Predictors of alternative medicine use by multiple sclerosis patients. Mult. Scler. 9 (2003), 461–466.
24. Martin, R., McFarland, H.F., Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32 (1995), 121–182.
25. Matthaus, B., Ozcan, M., Glucosinolates and fatty acid, sterol, and tocopherol composition of seed oils from Capparis spinosa Var. spinosa and Capparis ovata Desf. Var. canescens (Coss.) Heywood. J. Agric. Food Chem. 53 (2005), 7136–7141.
26. Nie, L., Wu, G., Zhang, W., Correlation between mRNA and protein abundance in Desulfovibrio vulgaris: a multiple regression to identify sources of variations. Biochem. Biophys. Res. Commun. 339 (2006), 603–610.
27. Ozcan, M., Mineral composition of different parts of Capparis ovata Desf. var. canescens (Coss.) heywood growing wild in Turkey. J. Med. Food 8 (2005), 405–407.
28. Ozgun, O., Arslan, S., Sen, A., An efficient preparation for potential treatment of multiple sclerosis—Capparis ovata extract—MSCov: molecular results. Turk. J. Biochem. 37 (2012), 120–121.
29. Panico, A.M., Cardile, V., Garufi, F., Puglia, C., Bonina, F., Ronsisvalle, G., Protective effect of Capparis spinosa on chondrocytes. Life Sci. 77 (2005), 2479–2488.
30. Paxinos, G., Franklin, K.B.J., The Mouse Brain in Stereotaxic Coordinates. 2004, Elsevier Academic Press, Amsterdam; Boston.
31. Rostami, A., Ciric, B., Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J. Neurol. Sci. 333 (2013), 76–87.
32. Schmidt, S., Candidate autoantigens in multiple sclerosis. Mult. Scler. 5 (1999), 147–160.
33. Schmidt, M.W., Houseman, A., Ivanov, A.R., Wolf, D.A., Comparative proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe. Mol. Syst. Biol., 3, 2007, 79.
34. Schmitz, K., Barthelmes, J., Stolz, L., Beyer, S., Diehl, O., Tegeder, I., “Disease modifying nutricals” for multiple sclerosis. Pharmacol. Ther. 148 (2015), 85–113.
35. Schwarz, S., Knorr, C., Geiger, H., Flachenecker, P., Complementary and alternative medicine for multiple sclerosis. Mult. Scler. 14 (2008), 1113–1119.
36. Sen, A., Arinc, E., Preparation of highly purified cytochrome P4501A1 from leaping mullet (Liza saliens) liver microsomes and its biocatalytic, molecular and immunochemical properties. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 121 (1998), 249–265.
37. Steinman, L., Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194 (2001), F27–F30.
38. Tajouri, L., Fernandez, F., Griffiths, L.R., Gene expression studies in multiple sclerosis. Curr. Genomics 8 (2007), 181–189.
39. Tlili, N., Munne-Bosch, S., Nasri, N., Saadaoui, E., Khaldi, A., Triki, S., Fatty acids, tocopherols and carotenoids from seeds of tunisian caper “Capparis spinosa”. J. Food Lipids 16 (2009), 452–464.
40. Tlili, N., Trabelsi, H., Renaud, J., Khaldi, A., Mayer, P.M., Triki, S., Triacylglycerols and phospholipids composition of caper seeds (Capparis spinosa). J. Am. Oil Chem. Soc. 88 (2011), 1787–1793.
41. Tuzun, F., Kumral, A., Dilek, M., Ozbal, S., Ergur, B., Yesilirmak, D.C., Duman, N., Yilmaz, O., Ozkan, H., Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain. J. Matern. Fetal Neonatal Med. 25 (2012), 849–854.
42. Yadav, V., Narayanaswami, P., Complementary and alternative medical therapies in multiple sclerosis—the American Academy of Neurology guidelines: a commentary. Clin. Ther. 36 (2014), 1972–1978.
43. Yadav, V., Shinto, L., Bourdette, D., Complementary and alternative medicine for the treatment of multiple sclerosis. Expert. Rev. Clin. Immunol. 6 (2010), 381–395.
44. Zamvil, S.S., Steinman, L., The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8 (1990), 579–621.